Advertising

Research
Volume 52, Issue 7, July 2023

Barriers to progression through Australian obesity management pathways: Survey data from the ACTION-IO study

Georgia Rigas    Kathryn Williams    Priya Sumithran    Wendy A Brown    Ian D Caterson   
doi: 10.31128/AJGP-07-22-6501   |    Download article
Cite this article    BIBTEX    REFER    RIS

Background and objectives

Our previous work uncovered a nine-year delay, from when Australian people with obesity (PwO) first began struggling with excess weight and first discussed weight with a healthcare professional (HCP). In this study we explore barriers to having an obesity consultation, making and discussing the diagnosis of obesity and arranging a management plan, including a follow-up appointment.

Methods

Australian PwO (n = 1000) and HCPs (n = 200; 50% general practitioners [GPs]), completed the Awareness, Care & Treatment In Obesity Management – An International Observation (ACTION-IO) online survey.

Results

Of Australian PwO, 53% had discussed weight with an HCP in the past five years, 25% were informed of their obesity diagnosis and 15% had weight-related follow-up appointments scheduled. Fewer GPs than other specialists reported recording obesity diagnoses, but GPs scheduled more follow-up appointments. Receiving formal obesity training was reported by 22% of GPs and 44% of other specialists.

Discussion
Barriers to obesity care in Australia include unrealistic expectations from both PwO and HCPs, lack of evidence-based strategies and insufficient training. Further exploration of barriers is required.
 

Australia has one of the highest obesity rates in the world,1,2 with a combined prevalence of overweight and obesity of at least 60%.3 Australian clinical practice guidelines base obesity treatment on body mass index (BMI) and complication status.2,4 Healthcare professionals (HCPs) report having limited training and few effective therapeutic approaches and/or tools at their disposal,5–7 and obesity stigma inhibits the deployment of effective strategies at both individual and population levels.7,8

There is significant inequity in accessing effective treatments in the Australian health system, particularly allied health support, adjunctive medical therapies and bariatric surgery.9 This is due, in part, to reported lack of HCP knowledge and training, inadequate integrated clinical services for obesity management, particularly in rural and remote areas,9 a funding system with restricted reimbursement for obesity management10 and inequitable access to effective publicly funded treatments.9

The Awareness, Care & Treatment In Obesity Management – An International Observation (ACTION-IO) study (NCT03584191) was a cross-sectional survey conducted in 11 countries. The study aimed to investigate the attitudes, behaviours and perceptions of people with obesity (PwO) and HCPs regarding obesity management.11 The results showed a nine-year delay between Australian PwO beginning to struggle with weight and first discussing their weight with an HCP,11 whereas the global ACTION-IO analysis found a mean delay of six years.12 During this period, many PwO will develop complications of obesity13 and/or progress to more severe stages of obesity.14 In this paper we explore barriers to effective and comprehensive obesity care in Australia, including barriers to having an obesity consultation, making and discussing the diagnosis of obesity and arranging a management plan that includes a follow-up appointment.

Methods

The cross-sectional, non-interventional, descriptive ACTION-IO study collected PwO and HCP data via an online survey in 11 countries.11,12 Full methodologies, including recruitment strategies, have been published elsewhere.11,12 The survey responses were self-reported and not verified. Australian data were collected between 13 September and 10 October 2018 and are reported here. The online survey was programmed by the third-party vendor, KJT Group (Honeoye Falls, NY, USA), who also oversaw data collection. Data analysis was conducted by KJT Group using SPSS version 23.0 (IBM Corp., Armonk, NY, USA), Stata version IC 14.2 (StataCorp, College Station, TX, USA) and Excel 2016 (Microsoft, Bellevue, WA, USA).

The study inclusion criteria for HCPs defined them as medical doctors with two or more years of clinical experience, who spent ≥70% of work time in direct patient care and had seen ≥10 patients with obesity in the preceding month. General, plastic or bariatric surgeons were excluded to avoid response bias because these specialities do not typically provide long-term care to patients. HCPs were not targeted demographically, and data are unweighted. All authors had access to all data in the study, which was approved by the University of Sydney Human Ethics Committee (Project no. 2018/591).

To be eligible for inclusion in this study, PwO recruited in Australia had to be aged ≥18 years with a BMI of ≥30 kg/m2 (based on self-reported height and weight), not pregnant, not participating in intense fitness programs or body building, not having experienced significant unintentional weight loss in the six months prior and willing to provide information concerning income or race/ethnicity. Demographic targeting and weighting ensured that the PwO group was representative of the general population.

Results

Perceptions of obesity as a disease

Response rates and PwO and HCP characteristics have been reported elsewhere.11 General practitioners (GPs; n = 100) constituted 50% of the HCPs surveyed. The ‘other specialist HCPs’ (n = 100) were predominantly cardiologists (n = 50) and endocrinologists (n = 41). Most PwO (76%), and even more HCPs (98%), agreed that obesity is a chronic disease. Most PwO (89%) and HCPs (91%) felt that society and the Australian healthcare system were not meeting the needs of PwO.

Among the Australian PwO surveyed who had discussed weight/weight loss with an HCP in the past five years, the mean delay between the PwO beginning to struggle with weight and first discussing their weight with an HCP was nine years (reported previously11). To obtain these data, PwO were asked at what age they had first struggled with weight, and their age when an HCP first discussed their excess weight or recommended that they lose weight. The time gap between these two periods was calculated for each individual respondent and the results are summarised in Figure 1A; 72% of respondents were aged at least 36 years when they began these conversations.


Figure 1. Self-reported weight management experience of people with obesity (PwO) in Australia.

Figure 1. Self-reported weight management experience of people with obesity (PwO) in Australia. Healthcare providers with whom weight was discussed. Click here to enlarge

A. Number of years between PwO first becoming concerned about their weight and having discussions about weight management with a healthcare professional (HCP). B. Proportion of Australian PwO reaching each stage of the obesity management pathway as reported by PwO. Of all the PwO who were surveyed, 53% had discussed weight/weight loss with an HCP in the past five years, 47% of those (25% of all PwO) reported receiving a diagnosis of obesity and 29% of those (15% of all PwO) had a follow-up appointment scheduled specifically regarding weight. C. HCPs with whom Australian PwO report having ever discussed their weight. Percentage values are weighted to demographic targets.

*Data on obstetrician/gynaecologist not collected for males. GP, general practitioner.


Weight management discussions and obesity diagnosis

Australian chronic disease management guidelines recommend systematic discussion, assessment, goal-setting and follow up.15 However, despite widespread global recognition of obesity as a chronic disease, there were marked reductions in the proportion of patients progressing through an obesity care pathway from discussion to diagnosis and then to follow up (Figure 1B). In this self-reported survey, although 53% of PwO had discussed weight/weight loss with an HCP in the past five years, only half (25% of all PwO) of those had been formally diagnosed with obesity, and 29% (15% of all PwO) had a follow-up appointment scheduled specifically regarding weight. Most (96%) PwO with a follow-up appointment scheduled reported that they had attended or expected to attend their appointment. Their GP was the most common HCP with whom PwO had discussed weight (Figure 1C).

GPs reported discussing weight with 69% of their patients with obesity (Figure 2A), and that 39% of these conversations were initiated by patients. Other specialist HCPs stated that such conversations took place with 82% of their patients with obesity (Figure 2A), and that patients broached the subject 24% of the time. Both GPs and other specialists reported informing 66% of their patients of their obesity diagnosis (Figure 2A). Less than one-quarter of both groups stated that an obesity diagnosis is always recorded in their patients’ medical records (Figure 2B). Fewer GPs than other specialists reported recording the diagnosis ‘most of the time’. GPs scheduled follow-up appointments regarding weight management with a higher proportion of patients than other specialist HCPs (Figure 2A).


Figure 2. Healthcare professional (HCP)-reported weight management experience in Australia.

Figure 2. Healthcare professional (HCP)-reported weight management experience in Australia. Click here to enlarge

A. Proportions of patients with obesity for whom general practitioners (GPs) and other specialist HCPs report discussing weight, informing of an obesity diagnosis and arranging follow-up appointments related to weight. B. Frequency of recording obesity diagnoses in patients’ medical records, journals, or histories, as reported by GPs and other specialist HCPs. Percentage values are weighted to demographic targets.


Setting and meeting expectations for weight loss

Most PwO (58%) would set a goal of >10% body weight loss (mean 14%) and reported a mean 19% weight loss to reach their ‘ideal’ weight. PwO who discussed goals with HCPs reported HCP-recommended weight loss targets of a mean of 14%, which, although aligned with PwO goals, is higher than the 5–10% typically achievable by non-surgical therapies currently available in Australia.16

In this self-reported study, 5–10% weight loss was rarely met and maintained, highlighting the difficulties of weight loss in the face of metabolic adaptation. Only 36% of PwO reported having lost ≥5% body weight over the past three years. Of those, only 27% maintained this for one year or more (10% of the total PwO cohort in this study). At least 10% weight loss was reported by 16% of PwO over the same period; only 35% of these PwO maintained this weight loss for one year or more (5% of the total PwO cohort in this study).

Methods for managing weight

Methods for weight management most often recommended by both GPs and other specialist HCPs were dietary changes/healthy eating and exercise (Figure 3). Although reliance on general lifestyle changes alone may be insufficient to meet weight loss targets set by HCPs and PwO,17 formal programs and expert referrals were less frequently recommended.

Other specialists reported that they were more likely to recommend nutritionist/dietitian review or bariatric surgery than GPs. GPs more frequently reported recommending prescription weight loss medication. PwO having discussed weight with their HCP and made weight loss efforts reported receiving the same recommendations, but with lower percentages for most methods (Figure 3).


Figure 3. Methods for managing weight recommended or discussed between healthcare professionals (HCPs) and people with obesity (PwO).

Figure 3. Methods for managing weight recommended or discussed between healthcare professionals (HCPs) and people with obesity (PwO). General practitioners (GPs) and other specialist HCP data reflect the proportions of patients for which HCPs reported recommending each method. PwO data reflect the percentage of patients who reported they had discussed each method with their HCP. Percentage values are weighted to demographic targets. QoL, quality of life. Click here to enlarge


Thirty-nine per cent of PwO and 59% of HCPs perceived that the prices of obesity medication, programs and services were barriers to weight loss. Most PwO respondents reported they would rather lose weight without the use of medication (70%) or bariatric surgery (83%). Fewer other specialist HCPs (51%) and still fewer GPs (32%) thought their patients would rather lose weight without using medication. Similarly, 42% of other specialists and 28% of GPs thought patients would rather have surgery than use lifestyle measures alone. The reasons for this were not explored in this survey.

More other specialists than GPs considered themselves ‘experts’ in obesity management and/or worked in an obesity clinic (56% vs 37%) and reported receiving formal training in obesity treatment (44% vs 22%; Figure 4A).

GPs and other specialist HCPs reported that a mean of 31% of their patients did not follow their recommendations (Figure 4B).


Figure 4. Healthcare professional (HCP) classifications and perceptions of patients following weight management suggestions in Australia.

Figure 4. Healthcare professional (HCP) classifications and perceptions of patients following weight management suggestions in Australia. Click here to enlarge

A. Self-reported obesity expert classifications, as reported by general practitioners (GPs) and other specialist HCPs. B. Proportion of patients with obesity who follow recommendations, as perceived by HCPs. Data reflect the proportions of GPs and other specialist HCPs selecting each category as their response. Percentage values are weighted to demographic targets. Values in the other specialist HCP chart do not total 100% because percentages have been rounded.


Discussion

The recognition by HCPs and PwO of obesity as a chronic disease is not reflected in clinical practice, as evidenced by inadequate discussion, diagnosis and follow up. Based on earlier published data,6,11,12 barriers potentially contributing to this include time constraints, limited tools available, insufficient obesity training, costs of obesity treatment and a low expected likelihood of the preferred weight loss methods achieving the desired outcomes. Similar barriers to those identified in the present study have been reported previously as having interdependent effects, potentially further hindering effective weight management.18

In general practice, there is a system of timed appointments and limited time allocation for administration duties.19 GPs often manage comorbid conditions in one consultation, which may be of insufficient length to address patient concerns;19 between 2015 and 2016, the mean duration of consultations was 14.9 minutes.1 Furthermore, GP-targeted tools for obesity management in particular are limited,20 and primary obesity care could benefit from an improved availability of resources.21

GPs are an important initial contact for many PwO and play a key role in initiating obesity management care.22 Given that at least 60% of Australians have overweight or obesity,3,22 most of the patients seen by GPs are living with the condition regardless of whether their appointments relate to weight. A critical need to increase the frequency of GPs initiating weight management discussions was identified here. With appropriate resources, it could be possible to manage complex medical diseases such as obesity effectively and safely over a series of approximately nine consultations, as has been reported elsewhere.23

Prior studies reported that HCPs have limited undergraduate and postgraduate obesity training and few effective therapeutic options at their disposal.5,6 The hesitance of HCPs to discuss weight with patients, for example to avoid offence, has been attributed to inadequate training on communication and underlying causes of obesity.24 Further training is required to provide HCPs with the knowledge and tools to initiate weight discussions with patients. HCPs broaching the topic and offering support as early as possible is important to limit the perception harboured by PwO that weight loss is entirely their own responsibility, as reported previously.11 This could also halt the progression to more severe stages of obesity and/or the development of obesity-related health complications.13 Upskilling may also increase the frequency and quality of follow-up appointments.

Training regarding the correct diagnosis and staging of obesity may also help improve the progression of PwO through the weight management pathway. Documentation of obesity diagnoses by HCPs and discussion of the diagnosis with PwO have been shown to increase the likelihood of patients having a formal management strategy, making concerted weight loss efforts and reporting clinically meaningful weight loss.25–27 Awareness of an obesity diagnosis may also inform of an individual’s vulnerability to associated complications,28 and therefore facilitate appropriate management. Our results further support the limited Australian data available on reporting of obesity consultations and diagnosis documentation, which indicate shortcomings in Australia. For example, of patients seen in inner-eastern Melbourne general practice clinics, 22.0% had their BMI documented and 4.3% had their waist circumference documented.29 In an Australia-wide report, 0.5% of total problems addressed in consultations by GPs across Australia related to obesity.1 A higher proportion of other specialist HCPs than GPs in our Australian cohort reported documenting obesity diagnoses. The level of obesity expertise potentially contributes to the differences between GP and other specialist practice; notably, fewer GPs than other specialists met the self-reported criteria for ‘obesity specialist’, as may be expected given the important role of GPs as ‘generalists’. The proportion of HCPs who self-reported receiving formal obesity management training was low for both groups (GPs and other specialists), but more so for GPs.

HCPs perceiving that their advice is not being followed may contribute to the insufficient progression of PwO through management pathways and lack of follow up. The difficulty in maintaining weight loss, even when recommendations are followed,25 could further this perception, especially if there is inadequate understanding of metabolic adaptation. A better understanding of the science could help reduce the weight shame and stigma many PwO experience. Moreover, the high weight loss targets set by PwO and HCPs in Australia reported here are impractical considering the methods primarily recommended. Targets should be informed by clinical evidence and complemented by recommendations of appropriate strategies. Thus, improved education on realistic goals and evidence-based weight management approaches may alleviate the difficulties experienced by PwO in achieving and maintaining weight loss targets.

In this survey, Australian HCP recommendations for weight management focused primarily on lifestyle changes alone, and less so on adjunct therapies such as the addition of anti-obesity medication and/or bariatric surgery. Compared with the global HCP cohort, Australian HCPs reported recommending general lifestyle changes to a higher percentage of patients, with general improvements in physical activity levels recommended to 62% of global patients versus 70% and 75% of Australian GP and other specialist patients, respectively.12 In contrast, global HCPs more frequently recommended visiting an obesity specialist (23%) than did Australian GPs (9%) and other specialists (15%).12 Thus, Australian HCPs may benefit from further training/upskilling, greater support and resources to implement interventions beyond general lifestyle advice alone.

Increased awareness of the biological mechanisms contributing to obesity and weight relapses and the importance of support, rather than stigmatising behaviour towards PwO struggling to maintain a healthy weight, is also required.25,28,30–32 The Royal Australasian College of Physicians, the Australian and New Zealand Obesity Society and the Australian and New Zealand Metabolic and Obesity Surgery Society recognise obesity as a chronic disease,33–37 as did most Australian PwO and HCPs in the present study. Further recognition across Australia of obesity as a chronic disease may challenge the misconception that PwO are solely to blame for their weight, reduce stigma surrounding obesity and enable more appropriate approaches to obesity management. Follow-up appointments should be arranged after weight management discussions, as is best practice for chronic diseases. The Royal Australian College of General Practitioner’s Red Book (9th edn) recommends that GPs routinely measure BMI and waist circumference and help PwO develop a maintenance program that includes support, monitoring and relapse-prevention strategies,15 consistent with the recently published National Obesity Strategy.38

At the time of writing, there were no anti-obesity medications subsidised by the Pharmaceutical Benefits Scheme and only approximately 12% of bariatric surgery was performed in public hospitals.39 Indeed, many Australian HCPs in the present study felt that the costs of anti-obesity medication and programs for obesity management are barriers to weight loss, inequities experienced most by PwO of lower socioeconomic status. The fee-for-service structure currently used for primary care in Australia may also contribute to the inadequate progression of PwO through treatment pathways.

Strengths and limitations

HCP responses may have had a degree of bias, because many identified themselves as obesity specialists. In theory, this should have influenced study outcomes towards more evidence-based obesity management. There are limitations with grouping different types of HCPs together, as done here, because the experiences and available treatment pathways can differ. Furthermore, HCPs may recommend weight management to PwO to address other health conditions, such as osteoarthritis or diabetes, which may have had confounding effects in the present study. In addition, the PwO surveyed are not necessarily patients of the HCPs surveyed, and PwO and HCPs who responded may have personal interests in the topic. Data were self-reported and not verified. A unique shortcoming for Australia was the short recruitment period compared with the global cohort (one month versus four months). However, the response rate was consistent with similar survey-based studies.11

Conclusion

The Australian healthcare system does not address the needs of PwO effectively. Remaining barriers to obesity care include unrealistic weight loss expectations for the methods being most frequently recommended and the costs and availability of integrated clinical services and effective evidence-based strategies. Our self-reported data highlight opportunities for more formal, widespread training. Further exploration of barriers and enablers to obesity management in clinical practice will be important in developing adequate solutions.

Competing interests: WAB received travel expenses, and GR, KW, and IDC received personal fees, from Novo Nordisk to attend the ACTION-IO Australia author meeting. GR reports having received consulting fees from Novo Nordisk Pharmaceuticals Global & Australia, iNova Pharmaceuticals Australia and Nestle HealthScience for participation in data safety monitoring or advisory boards outside the submitted work. Furthermore, GR has received consulting fees from the NSW Ministry of Health, the Australian Department of Health, the Royal Australian College of General Practitioners (RACGP), Johnson & Johnson, Reshape HealthSciences, W.L. Gore & Associates and Ethicon Australia outside the submitted work. GR is also doing some consultancy work for Gila Therapeutics Inc. for which she is not paid. GR received support for meeting attendance/travel from the RACGP, Novo Nordisk Pharmaceuticals Global & Australia and iNova Pharmaceuticals Australia outside the submitted work. She is the Senior Bariatric Medical Practitioner at a private bariatric medical and surgical unit in Australia and was Founding Chair of the RACGP Obesity Management Network from 2015 to 2020. KW reports grants or contracts from Eli Lilly and Company and Boehringer Ingelheim for involvement in clinical trials; honoraria for participating in special advisory groups from Pfizer, Novo Nordisk and Eli Lilly and Company; and personal speaker fees from Novo Nordisk outside the submitted work. KW was an honorary member of the not-for-profit Kellion Diabetes Foundation until 2021. PS has received payment from Novo Nordisk for a lecture unrelated to the submitted work and grants from the National Health and Medical Research Council (NHMRC; paid to her institution) outside the submitted work. PS chaired an unsponsored data safety monitoring board for a clinical trial, is a council member of the Australian and New Zealand Obesity Society and a member of the leadership group of ‘The Collective’, none of which she has been paid for. WAB reports personal fees from W.L. Gore & Associates and Merck Sharp and Dohme (MSD) for lectures; personal fees from MSD, Novo Nordisk and Pfizer for participation in data safety monitoring or advisory boards; grants from Johnson & Johnson, W.L. Gore & Associates, Novo Nordisk, Medtronic, Applied Medical and Myerton; and grants from the NHMRC and Commonwealth of Australia outside the submitted work. She is also the chair for the Victorian Perioperative Consultative Council Surgical Sub-Committee, for which she is not paid, and a surgeon who performs bariatric surgery. IDC reports personal fees from Novo Nordisk (as chair of the ACTION-IO steering committee); grants from Novo Nordisk for medical writing and to support the ACTION-IO study; grants or contracts for clinical trial involvement from Rhythm Pharmaceuticals, Eli Lilly and Company and Boehringer Ingelheim outside the submitted work. IDC is a board member of Obesity Australia and a past president of the World Obesity Federation.
Provenance and peer review: Not commissioned, externally peer reviewed.
Funding: PS is supported by an Investigator Grant (1178482) from the NHMRC. This study was sponsored by Novo Nordisk, which also provided financial support for medical editorial assistance from Sari Cumming and Abbie Saunders PhD, of Articulate Science, UK.
Correspondence to:
drgeorgiarigas@gmail.com
Acknowledgements
The authors acknowledge Jessica Swinbourne and Mark Harris for their contribution to the early interpretation of results.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Britt H, Miller GC, Henderson J, et al. General practice activity in Australia 2015–16. Sydney: Sydney University Press, 2016. Search PubMed
  2. Grima M, Dixon JB. Obesity – recommendations for management in general practice and beyond. Aust Fam Physician 2013;42(8):532–41. Search PubMed
  3. Keramat SA, Alam K, Al-Hanawi MK, Gow J, Biddle SJH, Hashmi R. Trends in the prevalence of adult overweight and obesity in Australia, and its association with geographic remoteness. Sci Rep 2021;11(1):11320. doi: 10.1038/s41598-021-90750-1. Search PubMed
  4. Markovic TP, Proietto J, Dixon JB, et al. The Australian obesity management algorithm: A simple tool to guide the management of obesity in primary care. Obes Res Clin Pract 2022;16(5):353–63. doi: 10.1016/j.orcp.2022.08.003. Search PubMed
  5. McGowan BM. A practical guide to engaging individuals with obesity. Obes Facts 2016;9(3):182–92. doi: 10.1159/000445193. Search PubMed
  6. Petrin C, Kahan S, Turner M, Gallagher C, Dietz WH. Current attitudes and practices of obesity counselling by health care providers. Obes Res Clin Pract 2017;11(3):352–59. doi: 10.1016/j.orcp.2016.08.005. Search PubMed
  7. Petrin C, Kahan S, Turner M, Gallagher C, Dietz WH. Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals. Obes Sci Pract 2016;2(3):266–71. doi: 10.1002/osp4.53. Search PubMed
  8. Brown I, Flint SW. Weight bias and the training of health professionals to better manage obesity: What do we know and what should we do? Curr Obes Rep 2013;2(4):333–40. doi.org/10.1007/s13679-013-0070-y Search PubMed
  9. Atlantis E, Kormas N, Samaras K, et al. Clinical obesity services in public hospitals in Australia: A position statement based on expert consensus. Clin Obes 2018;8(3):203–10. doi: 10.1111/cob.12249. Search PubMed
  10. PricewaterhouseCoopers (PwC). Weighing the cost of obesity: A case for action. Melbourne: PwC, 2015. Available at www.pwc.com.au/publications/healthcare-obesity.html [Accessed 13 March 2023]. Search PubMed
  11. Rigas G, Williams K, Sumithran P, et al. Delays in healthcare consultations about obesity – barriers and implications. Obes Res Clin Pract 2020;14(5):487–90. doi: 10.1016/j.orcp.2020.08.003. Search PubMed
  12. Caterson ID, Alfadda AA, Auerbach P, et al. Gaps to bridge: Misalignment between perception, reality and actions in obesity. Diabetes Obes Metab 2019;21(8):1914–24. doi: 10.1111/dom.13752. Search PubMed
  13. Bray GA. A guide to obesity and the metabolic syndrome: Origins and treatment. New York: CRC Press: Taylor and Francis Group, 2011. doi: 10.1201/b10790. Search PubMed
  14. Kværner AS, Hang D, Giovannucci EL, Willett WC, Chan AT, Song M. Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin–insulin-like growth factor system. Am J Clin Nutr 2018;108(2):388–97. doi: 10.1093/ajcn/nqy103. Search PubMed
  15. The Royal Australian College of General Practitioners, National Preventive and Community Medicine Committee. Guidelines for preventive activities in general practice. Aust Fam Physician 2001;Spec No:S1i-xvi, S1–1–61. Search PubMed
  16. Australian Product Information. Saxenda®. Liraglutide solution for injection. Available at www.novonordisk.com.au/content/dam/nncorp/au/en/pdfs/2021-pi-and-cmi-pdfs/Saxenda%20pi-v5.pdf [Accessed 16 March 2023]. Search PubMed
  17. Sbraccia P, Busetto L, Santini F, Mancuso M, Nicoziani P, Nicolucci A. Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study. Eat Weight Disord 2021;26(3):817–28. doi: 10.1007/s40519-020-00907-6. Search PubMed
  18. Norman K, Chepulis L, Burrows L, Lawrenson R. Barriers to obesity health care from GP and client perspectives in New Zealand general practice: A meta-ethnography review. Obes Rev 2022;23(10):e13495. doi: 10.1111/obr.13495. Search PubMed
  19. Strazdins E, Dwan K, Pescud M, Strazdins L. Part-time in general practice – a remedy to a time-based problem? Fam Pract 2019;36(4):511–15. doi: 10.1093/fampra/cmy116. Search PubMed
  20. Sturgiss EA, Douglas K. A collaborative process for developing a weight management toolkit for general practitioners in Australia – an intervention development study using the knowledge to action framework. Pilot Feasibility Stud 2016;2:20. doi: 10.1186/s40814-016-0060-4. Search PubMed
  21. Sturgiss E, Haesler E, Elmitt N, van Weel C, Douglas K. Increasing general practitioners’ confidence and self-efficacy in managing obesity: A mixed methods study. BMJ Open 2017;7(1):e014314. doi: 10.1136/bmjopen-2016-014314. Search PubMed
  22. The Royal Australian College of General Practitioners (RACGP). Position statement: Obesity prevention and management. East Melbourne: RACGP, 2019. Available at www.racgp.org.au/advocacy/position-statements/view-all-position-statements/clinical-and-practice-management/obesity-prevention-and-management [Accessed 13 March 2023]. Search PubMed
  23. Forgione N, Deed G, Kilov G, Rigas G. Managing obesity in primary care: Breaking down the barriers. Adv Ther 2018;35(2):191–98. doi: 10.1007/s12325-017-0656-y. Search PubMed
  24. Auckburally S, Davies E, Logue J. The use of effective language and communication in the management of obesity: The challenge for healthcare professionals. Curr Obes Rep 2021;10(3):274–81. doi: 10.1007/s13679-021-00441-1. Search PubMed
  25. Dicker D, Alfadda AA, Coutinho W, et al. Patient motivation to lose weight: Importance of healthcare professional support, goals and self efficacy. Eur J Intern Med 2021;91:10–16. doi: 10.1016/j.ejim.2021.01.019. Search PubMed
  26. Kahan SI. Practical strategies for engaging individuals with obesity in primary care. Mayo Clin Proc 2018;93(3):351–59. doi: 10.1016/j.mayocp.2018.01.006. Search PubMed
  27. Pool AC, Kraschnewski JL, Cover LA, et al. The impact of physician weight discussion on weight loss in US adults. Obes Res Clin Pract 2014;8(2):e131–39. doi: 10.1016/j.orcp.2013.03.003. Search PubMed
  28. Alfadda AA, Caterson ID, Coutinho W, et al. The 3 Ds – discussion, diagnosis and direction: Elements for effective obesity care by healthcare professionals. Eur J Intern Med 2021;91:17–25. doi: 10.1016/j.ejim.2021.01.012. Search PubMed
  29. Turner LR, Harris MF, Mazza D. Obesity management in general practice: Does current practice match guideline recommendations? Med J Aust 2015;202(7):370–72. doi: 10.5694/mja14.00998. Search PubMed
  30. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365(17):1597–604. doi: 10.1056/NEJMoa1105816. Search PubMed
  31. Ghanemi A, Yoshioka M, St-Amand J. Broken energy homeostasis and obesity pathogenesis: The surrounding concepts. J Clin Med 2018;7(11):453. doi: 10.3390/jcm7110453. Search PubMed
  32. Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 2008;88(4):906–12. doi: 10.1093/ajcn/88.4.906. Search PubMed
  33. The Royal Australasian College of Physicians (RACP). RACP position statement on obesity: Action to prevent obesity and reduce its impact across the life course. Sydney: RACP, 2018. Available at www.racp.edu.au/docs/default-source/advocacy-library/racp-obesity-position-statement.pdf?sfvrsn=6e3b0b1a_5. [Accessed 29 November 2021]. Search PubMed
  34. Opie CA, Haines HM, Ervin KE, Glenister K, Pierce D. Why Australia needs to define obesity as a chronic condition. BMC Public Health 2017;17(1):500. doi: 10.1186/s12889-017-4434-1. Search PubMed
  35. Obesity Australia. Obesity as a chronic relapsing disease process. Sydney: Australian and New Zealand Obesity Society, [date unknown]. Available at https://static1.squarespace.com/static/5e3b5875edc1485d14d6fe3a/t/5ea170dc5636756e62bff52d/1587638495859/ANZOS-Statement.pdf [Accessed 29 October 2021]. Search PubMed
  36. Australian and New Zealand Metabolic and Obesity Surgery Society (ANZMOSS). Submission to Senate Select Committee into the obesity epidemic in Australia. Adelaide: ANSMOSS, [date unknown]. Available at www.aph.gov.au/DocumentStore.ashx?id=17b22033-16cc-423a-be9a-d70d1665f2da&subId=612942 [Accessed 29 November 2021]. Search PubMed
  37. Australian and New Zealand Metabolic and Obesity Surgery Society (ANZMOSS), Collaborative Public Bariatric Surgery Taskforce (CPBST). Public bariatric surgery: A national framework. Adelaide: ANSMOSS, [date unknown]. Available at https://anzmoss.com.au/wp-content/uploads/Public-Bariatric-Surgery-Framework_full-report.pdf [Accessed 29 November 2021]. Search PubMed
  38. Commonwealth of Australia. National obesity strategy 2022–2032. Health Ministers Meeting. Canberra: Commonwealth of Australia as represented by the Health Ministers Meeting, 2022. Available at www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf [Accessed 15 September 2022]. Search PubMed
  39. Bariatric Surgery Registry, Monash University. Bariatric Surgery Registry seventh annual report: 2018/19. Melbourne: Bariatric Surgery Registry, Monash University, 2019. Available at www.monash.edu/__data/assets/pdf_file/0006/1953438/316765-Bariatric-Surgery-Registry-2019_FINALv3WEB-.pdf [Accessed 29 November 2021]. Search PubMed

Obesity

Download article